Literature DB >> 8376698

The epidemiology of heart failure: the Framingham Study.

K K Ho1, J L Pinsky, W B Kannel, D Levy.   

Abstract

Congestive heart failure has become an increasingly frequent reason for hospital admission during the last 2 decades and clearly represents a major health problem. Data from the Framingham Heart Study indicate that the incidence of congestive heart failure increases with age and is higher in men than in women. Hypertension and coronary heart disease are the two most common conditions predating its onset. Diabetes mellitus and electrocardiographic left ventricular hypertrophy are also associated with an increased risk of heart failure. During the 1980s, the annual age-adjusted incidence of congestive heart failure among persons aged > or = 45 years was 7.2 cases/1,000 in men and 4.7 cases/1,000 in women, whereas the age-adjusted prevalence of overt heart failure was 24/1,000 in men and 25/1,000 in women. Despite improved treatments for ischemic heart disease and hypertension, the age-adjusted incidence of heart failure has declined by only 11%/calendar decade in men and by 17%/calendar decade in women during a 40-year period of observation. In addition, congestive heart failure remains highly lethal, with a median survival time of 1.7 years in men and 3.2 years in women and a 5-year survival rate of 25% in men and 38% in women.

Entities:  

Mesh:

Year:  1993        PMID: 8376698     DOI: 10.1016/0735-1097(93)90455-a

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  431 in total

1.  Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.

Authors:  Le Kang; Weijie Chen; Nicholas A Petrick; Brandon D Gallas
Journal:  Stat Med       Date:  2014-11-17       Impact factor: 2.373

Review 2.  Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?

Authors:  N Doba; H Tomiyama; T Nakayama
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 3.  Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.

Authors:  Vincent E Hagens; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C van Gelder
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

Review 4.  Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups.

Authors:  Shigetake Sasayama
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  A 66 year old woman with breathlessness: case outcome.

Authors:  Douglas Lowdon; Marion McMurdo
Journal:  BMJ       Date:  2004-04-17

Review 6.  Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?

Authors:  Kirkwood F Adams
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 7.  Systolic heart failure in the elderly: optimizing medical management.

Authors:  Jonathan P Man; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

8.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

9.  Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study.

Authors:  A M A Shehab; R J MacFadyen; M McLaren; R Tavendale; J J F Belch; A D Struthers
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 10.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.